Analyst Reco. Viatris Inc.

Equities

VTRS

US92556V1061

Market Closed - Nasdaq Other stock markets 21:15:00 03/05/2024 BST			5-day change	1st Jan Change
11.78 ^USD	+1.55%		+1.82%	+8.77%

04-18	Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says	MT
04-18	UK Regulator to Consider Undertakings for Theramex-Viatris Deal	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order	04-15	MT
Stonex Group Insider Sold Shares Worth $488,142, According to a Recent SEC Filing	03-25	MT
India's Nifty 50 set to open at new record high, buoyed by strong growth data	12-01	RE
Piper Sandler Adjusts Viatris' Price Target to $11 From $10, Maintains Neutral Rating	11-22	MT
Another clue on monetary policy?	11-08
BofA Securities Downgrades Viatris to Underperform From Neutral, Adjusts Price Target to $9 From $13	23/10/23	MT
UBS Adjusts Viatris Price Target to $11 From $12, Maintains Neutral Rating	20/10/23	MT
Out with the old	02/10/23
Inflation, Interest-Rate Prospects Lift Wall Street Pre-Bell; Asia, Europe Off	07/08/23	MT
Barclays Downgrades Viatris to Underweight From Equalweight, Price Target is $11	23/06/23	MT
Fitch Affirms IDR of Viatris at 'BBB'; Outlook Stable	26/04/23	AQ
Barclays Downgrades Viatris to Equal Weight From Overweight, $11 Price Target	24/04/23	MT
Barclays Adjusts Price Target on Viatris to $16 From $15, Keeps Overweight Rating	28/02/23	MT
BMO Capital Downgrades Viatris to Market Perform From Outperform, Adjusts Price Target to $14 From $16	17/02/23	MT
Barclays Adjusts Price Target on Viatris to $15 From $16, Maintains Overweight Rating	01/02/23	MT
Jefferies Upgrades Viatris to Buy From Hold, Adjusts Price Target to $15 From $13	27/01/23	MT
Indian shares set for muted open ahead of GDP data	30/11/22	RE
UBS Upgrades Viatris to Neutral From Sell, Adjusts Price Target to $12 From $9	10/11/22	MT
Piper Sandler Upgrades Viatris to Neutral From Underweight, Price Target is $10	08/11/22	MT
Barclays Adjusts Viatris' Price Target to $16 From $21, Reiterates Overweight Rating	25/10/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Viatris Inc.

Equities

VTRS

US92556V1061

Analyst Reco.

Filters